Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer
暂无分享,去创建一个
P. Bühlmann | G. Kristiansen | H. Moch | P. Schraml | Corinne Dahinden | P. Wild | V. Luu | M. Montani | G. Boysen | T. Sulser | B. Ingold
[1] B. Delahunt,et al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. , 2009, European urology.
[2] H. Moch,et al. Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma , 2009, Clinical Cancer Research.
[3] H. Moch,et al. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. , 2009, European urology.
[4] N. Probst-Hensch,et al. Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.
[5] W. Krek,et al. pVHL: A Multipurpose Adaptor Protein , 2008, Science Signaling.
[6] A. Vortmeyer,et al. Combined Vhlh and Pten Mutation Causes Genital Tract Cystadenoma and Squamous Metaplasia , 2008, Molecular and Cellular Biology.
[7] B. Jasani,et al. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma , 2008, British Journal of Cancer.
[8] S. Manna,et al. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. , 2008, The Journal of clinical investigation.
[9] J. Cheville,et al. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] C. Magi-Galluzzi,et al. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation. , 2007, Clinical genitourinary cancer.
[11] E. Cho,et al. p53 stabilization and transactivation by a von Hippel-Lindau protein. , 2006, Molecular cell.
[12] Patrick H. Maxwell,et al. Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma , 2005, Molecular and Cellular Biology.
[13] S. Signoretti,et al. Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer , 2005, Clinical Cancer Research.
[14] I. Sesterhenn,et al. World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .
[15] C. Supuran,et al. Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH , 2004, FEBS letters.
[16] V. Ficarra,et al. Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. , 2004, European urology.
[17] P. Rehak,et al. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique , 2004, Virchows Archiv.
[18] Ying Yan,et al. Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse. , 2004, Biochemical and biophysical research communications.
[19] William R Sellers,et al. The biology and clinical relevance of the PTEN tumor suppressor pathway. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Rehak,et al. Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? , 2004, Journal of Clinical Pathology.
[21] Ryan M. Anderson,et al. Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression , 2004, Molecular and Cellular Biology.
[22] Min Cheol Lee,et al. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth , 2003, Journal of surgical oncology.
[23] G. Landberg,et al. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray , 2003, British Journal of Cancer.
[24] Steve Horvath,et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] J. Cheville,et al. Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. , 2002, American journal of clinical pathology.
[26] Carlos L. Arteaga,et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization , 2002, Nature Medicine.
[27] Y. Oda,et al. Low expression of p27Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma , 2002 .
[28] D. Figarella-Branger,et al. Pax-2 expression in adult renal tumors. , 2001, Human pathology.
[29] P. Pandolfi,et al. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.
[30] H. Moch,et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.
[31] P. Chu,et al. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. , 2000, American journal of clinical pathology.
[32] Michele Pagano,et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.
[33] A. Schäffer,et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. , 1999, The American journal of pathology.
[34] J. Dixon,et al. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. , 1999, Trends in cell biology.
[35] H. Brauch,et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. , 1998, The Journal of urology.
[36] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[37] J. Herman,et al. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers , 1998, Oncogene.
[38] R. Klausner,et al. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Herman,et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. , 1997, Cancer research.
[40] B. Delahunt,et al. The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.
[41] J. Srigley,et al. Current prognostic factors‐renal cell carcinoma , 1997 .
[42] T. Pisansky,et al. Current prognostic factors--renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). , 1997, Cancer.
[43] P. Bugert,et al. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour , 1997, The Journal of pathology.
[44] G. Dressler,et al. The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. , 1996, The Journal of clinical investigation.
[45] P. Gruss,et al. Loss of p53 function through PAX‐mediated transcriptional repression. , 1995, The EMBO journal.
[46] J. Gnarra,et al. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. , 1995, Cancer research.
[47] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[48] Massimo Loda,et al. Role of p27 in Prostate Carcinogenesis , 2004, Cancer and Metastasis Reviews.
[49] Y. Oda,et al. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. , 2002, Cancer.
[50] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .